Detection of Disease in the Upper Tract
NCT05349812 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2024-04-09
Summary
An observational study of Cxbladder performance for detection or rule-out of upper tract urothelial cancer. Subjects will be prospectively recruited to a single arm observational study to validate the performance characteristics of Cxbladder for suspected (UTUC) or for patients with a history of UTUC and are under surveillance for recurrence of disease.
Conditions
- Upper Tract Urinary Carcinoma
Sponsors & Collaborators
-
Pacific Edge Limited
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-11-30
- Primary Completion
- 2023-12-31
- Completion
- 2023-12-31
More Related Trials
-
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
NCT01050504 ·Status: RECRUITING
-
Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer
NCT00872495 ·Status: RECRUITING
-
Cisplatin-Based Chemotherapy Followed by Maintenance Avelumab in UTUC
NCT07225374 ·Status: RECRUITING ·Phase: PHASE2
-
Intravesical Prostatic Protrusion Mimicking Urothelial Cell Carcinoma of the Bladder
NCT05077852 ·Status: UNKNOWN
-
Urinary Biomarkers in the Detection of Urothelial Carcinoma of the Bladder
NCT02745301 ·Status: COMPLETED
-
Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue
NCT02379429 ·Status: RECRUITING
-
Utility of Bladder EpiCheck for Detection of Recurrent Urothelial Carcinoma
NCT02647112 ·Status: COMPLETED ·Phase: NA
-
Diagnostic Accuracy of Optical Coherence Tomography in Upper Urinary Tract Urothelial Carcinoma
NCT02326909 ·Status: COMPLETED ·Phase: NA
-
Cystoscopic Imaging Collection and Enhancement pROject
NCT02427321 ·Status: COMPLETED
-
Registry for Treatment of Upper Urinary Tract Tumours
NCT02281188 ·Status: UNKNOWN
-
Study of the Combination of ACP-196 and Pembrolizumab in Subjects With Platinum Resistant Urothelial Bladder Cancer
NCT02351739 ·Status: COMPLETED ·Phase: PHASE2
-
Pembrolizumab in Combination With BCG After Ablation in Patients With UUTTCC Without Nephroureterectomy
NCT03345134 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
18Fluorine-Fluciclovine PET/CT for Staging Muscle Invasive Bladder Cancer Preceding Radical Cystectomy
NCT04018053 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
A Diagnostic for the Early Detection of Bladder Cancer
NCT05347342 ·Status: ACTIVE_NOT_RECRUITING
-
Bladder EpiCheck European Haematuria Study
NCT06818136 ·Status: RECRUITING
-
Prophylactic Intravesical Chemotherapy to Prevent Bladder Tumors After Nephroureterectomy for Primary Upper Urinary Tract Urothelial Carcinomas
NCT02547350 ·Status: UNKNOWN ·Phase: PHASE2
-
Clinical Evaluation of a Test for Monitoring the Recurrence of Bladder Cancer
NCT03125460 ·Status: COMPLETED
-
Identifying Methylation Biomarkers for Monitoring Bladder Tumors
NCT00244205 ·Status: UNKNOWN
-
Study of Cetuximab With and Without Weekly Paclitaxel for Patients With Previously Treated Advanced Urothelial Cancer
NCT00350025 ·Status: COMPLETED ·Phase: PHASE2
-
The Efficacy of the Bladder EpiCheck for Detection of Recurrent Urothelial Cell Carcinoma
NCT02700464 ·Status: COMPLETED ·Phase: NA
-
The Combined Role of FAPI PET and Liquid Biopsy in the Staging and Clinical Management of Bladder Cancer - FUTURE Trial
NCT07257718 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Bio Clinical Collection of Urothelial Carcinoma
NCT04970472 ·Status: RECRUITING
-
Intravesical BCG: is the Urinary Bladder Ready to Receive it
NCT05335512 ·Status: NOT_YET_RECRUITING
-
Analytical Specificity of Bladder EpiCheck Test in Healthy Population and Urology Patients Without Prior History or Evidence of Bladder Cancer
NCT06020807 ·Status: COMPLETED
-
New Models for the Evaluation of Preclinical Treatment for Urothelial Carcinomas of the Upper Excretory Tract.
NCT04944550 ·Status: UNKNOWN